IHI GREG

GREG - Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation and Use for Decision-Making in Europe. GREG is a public-private partnership supported by the Innovative Health Initiative Joint Undertaking (IHI JU), set to revolutionise Real-World Evidence (RWE) practices in Europe. The GREG initiative aims to create, test, and share practical, evidence-based guidance and tools to help generate and use RWE. By enhancing how RWE informs the development and evaluation of medicines, medical devices, and drug-device combinations, we will support better decision-making for regulators and Health Technology Assessment (HTA) bodies. Starting in May 2025, the GREG project will unfold over the next five years, bringing together 29 partner organisations from 15 countries. The GREG consortium is uniquely positioned to make a significant impact on European RWE practices. Led by Erasmus University Medical Center (The Netherlands) as the Coordinator, Novo Nordisk (Denmark) as the Project Lead, and Sanofi (France) as the Co-Lead, with support from the University of Oxford (United Kingdom), we are ready to make a difference. Curious to see how we are transforming healthcare? Follow us to stay updated and be part of the journey!